By Murtala Muhammad
Bauchi state government is targeting one point nine million children of one to fifty nine months, for the fourth round campaign of Azithromycin administration to guard them against diarrhoea trachoma and other infections
The Azithromycin administration campaign will commence on 27 October, 2026, targeting only to healthy children of the specified age bracket.
The Deputy State Health Educator, Bauchi States Primary Healthcare Board, Dabo Abubakar, stated this at a one-day Stakeholders’ Advocacy, Communication and Social Mobilisation (ACSM) Meeting, held in Bauchi metropolis.
Azithromycin is an antibiotic used to treat bacterial infections such as pneumonia, strep throat, sinus infections, middle ear infections and other infections.
Dabo Abubakar said to avoid inappropriate deals during the campaign, the Board would ensure that all its monitoring mechanisms are active, threatening to take serious measures against erring persons.
The meeting is aimed at ensuring smooth implementation of the campaign for Safety and Antimicrobial Resistance of Mass Administration of Azithromycin among Children aged one to fifty nine months in Nigeria (SARMAAN II) project.
While giving an Overview of SARMAAN II project, the Executive Director, MITOSATH Dr Francisca Olamiju said the project was introduced to reduce child mortality rate in Nigeria and Bauchi state was among the states with high mortality rate in the country.
Dr Olamiju, represented by Elizabeth Omotuyole said Azithromycin was being administered to eligible children after every six months, encouraging all stakeholders to take ownership for the successful implementation of the campaign.
The meeting brought together journalists, Civil Society Organisations, traditional and religious leaders among others.